Stay updated with breaking news from Rayze Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fusion Pharmaceuticals Inc.’s stock was up by 5.3% in premarket trading on Wednesday, as analysts at two firms talked up its prospects as a takeover target.…
Targeted-oncology specialist draws upgrade at Raymond James after big premium paid is for Rayze Bio.
The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.
The radiopharmaceuticals developer Ariceum Therapeutics has bagged $24.9m (€22.8m) in a Series A extension round. Adding to a $27.4m (€25m) Series A closing last year, the Series A winnings for the German startup now total $52.3m (€47.8m).